SCHEMBL30018366

SCHEMBL30018366

COc1cc(F)cc(-c2ncc(Cn3ncc4cc(Cl)ccc43)cn2)c1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 8/20 0.41
GRIN2B Q13224 8/20 0.41
SHMT2 P34897 1/20 0.40
RAB9A P51151 1/20 0.40
EPHX2 P34913 1/20 0.40
PPARG P37231 1/20 0.40
P2RX7 Q99572 1/20 0.39
KMO O15229 1/20 0.38
QPCT Q16769 1/20 0.38
QPCTL Q9NXS2 1/20 0.38
EGFR P00533 3/20 0.38
ERBB2 P04626 3/20 0.38
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
MET P08581 2/20 0.37
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30017722 0.92 GRIN1 (0.47) GRIN1GRIN2BEPHX2PPARGQPCT
SCHEMBL30018106 0.91 GRIN1 (0.39) GRIN1GRIN2BSHMT2RAB9AEPHX2
SCHEMBL30018748 0.86 GRIN1 (0.44) GRIN1GRIN2BSHMT2RAB9AKMO
SCHEMBL30017921 0.86 HTR2A (0.40) GRIN1GRIN2BEPHX2PPARGQPCT
SCHEMBL30017931 0.85 GRIN1 (0.43) GRIN1GRIN2BEPHX2PPARGEGFR
SCHEMBL30017725 0.84 SHMT2 (0.41) GRIN1GRIN2BSHMT2RAB9AEPHX2
SCHEMBL30018361 0.82 QPCT (0.47) GRIN1GRIN2BSHMT2RAB9AKMO
SCHEMBL30018866 0.80 SHMT2 (0.41) GRIN1GRIN2BSHMT2RAB9AEPHX2
SCHEMBL24784619 0.79 P2RX7 (0.38) GRIN1GRIN2BEPHX2PPARGP2RX7
SCHEMBL30103035 0.79 P2RX7 (0.38) GRIN1GRIN2BEPHX2PPARGP2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022257960-A1 BICYCLIC COMPOUND FOR THE TREATMENT OF EP2 AND EP4 RECEPTOR-MEDIATED DISEASES 武汉人福创新药物研发中心有限公司 2022-12-15 WO disclosed